AvertixMedical

First and only FDA-approved heart attack warning system. Empowering patients who have had prior ACS events, including silent MI. Keep moving with Guardian!

[AvertixMedical @AvertixMedical]

The Avertix Guardian System Confirmed as Cost-Effective for High-Risk Acute Coronary Syndrome Patients. https://t.co/DzD9c45GkC

[AvertixMedical @AvertixMedical]

Dr. C. Michael Gibson and Dr. Mehdi Khalafi discuss The Guardian® System by Avertix Medical Systems Inc., the first FDA-approved cardiac implant designed to detect acute coronary syndrome (ACS) events, including silent heart attacks. https://t.co/ZLmRIAYkS7

[AvertixMedical @AvertixMedical]

Dr. C. Michael Gibson (M.S., M.D. CEO non-profit Baim / PERFUSE Research Institute, Harvard Professor, Cardiologist BIDMC, Founder & Chairman https://t.co/8PdWLPvJMF) and Dr. Ashish Gupta. Learn More.
https://t.co/EqLCAkFHo9

[AvertixMedical @AvertixMedical]

Dr. C. Michael Gibson and Dr. Haroon Faraz discuss The Guardian® System by Avertix, the first FDA-approved cardiac implant for detecting ACS events, including silent heart attacks. Check the link! https://t.co/hYXQiPJFvH

[AvertixMedical @AvertixMedical]

GREAT NEWS FROM THE AVERTIX REIMBURSEMENT TEAM. #AVERTIX
SEE LINK BELOW
https://t.co/atkkJe6Y1y

[AvertixMedical @AvertixMedical]

Today, the Avertix family would like to express our deepest gratitude for all of the brave men and women who have served and sacrificed for the freedoms we enjoy as Americans! Thank you and God bless our veterans! #avertix #VeteransDay2024

[AvertixMedical @AvertixMedical]

Day Two at TCT and Avertix is going strong. Booth #3118 to learn about the Guardian! #TCT2024 #CardioInnovations

[AvertixMedical @AvertixMedical]

Join us for the Oklahoma Heart Guardian Experience, a premier gathering of healthcare leaders dedicated to advancing medical innovation and improving patient care. #symposium #futureofmedicine #MedSymposium2024

[AvertixMedical @AvertixMedical]

🌟Please stop by booth #3118 at TCT to discuss what a Guardian Program can do for your institution! #CardioInnovations #TCT2024 #AdvancingCardiology 🌟

[AvertixMedical @AvertixMedical]

🌟 Exciting Day at #SCAI2024! 🌟

Join @HaroonFarazMD today as he presents new clinical findings.

📅 May 2, 10:40am–12:10pm
📍 Poster A-42

#Avertix #GUARDIAN #medtech #heartattacks #keepingfamiliestogether

[AvertixMedical @AvertixMedical]

🌟 Join us at #SCAI2024, Booth 843!

Discover #GUARDIAN, the first and only FDA-approved #heartattack detection and warning system for early heart attack #detection.

#medtech #heartattack #Cardiology #CardioTwitter #CardioX

[AvertixMedical @AvertixMedical]

In The News: 📷 @tylerryan interviews Dr. Garrison Morgan of @MUSChealth Columbia about how #AvertixGUARDIAN revolutionizes heart attack detection. The device offers big peace of mind, alerting you to dangers before they escalate. #heartmonth https://t.co/QmUGdk8hXW

[AvertixMedical @AvertixMedical]

🚨@MUSChealth adopts GUARDIAN System, leading the way in heart attack detection with Dr. Garrison Morgan & team. A leap towards rapid response and MI detection. #MUSC #HeartHealth #HeartMonth #AvertixGuardian #CardioTwitter

[AvertixMedical @AvertixMedical]

🌟 #Guardian in the News! 🌟 @DrKevinCampbell discussed #AvertixGUARDIAN on 'Cavuto: Coast to Coast' - an AI device detecting heart attacks! #AIHealthTech is reshaping patient care, research, and changing the game in #medtech #cardiotwitter https://t.co/1HHka75FN2 👉#FoxBusiness

[AvertixMedical @AvertixMedical]

We’d like to thank @healthtechworld for the opportunity to discuss the Guardian System, how it’s helping patients take control of their lives, and potential features of the next-gen Guardian.

Read the interview with our CEO Tim Moran below.
https://t.co/rXNUssb7A9

[AvertixMedical @AvertixMedical]

Our CEO Tim Moran recently spoke to @KarenJagoda on the Empowered Patient Podcast. Listen to the interview and learn more about the #Guardian System and our mission to revolutionize how heart attack survivors are cared for and supported: https://t.co/p0XMrd2yCt
#CardioTwitter

[AvertixMedical @AvertixMedical]

Exciting news! 🚀 Our high-fidelity, continuous intracardiac monitoring, as featured in @MassDevice, reveals a remarkable 150% increase in medication adjustments to transform long-term care for heart attack survivors. Read more: https://t.co/RrjAXZ9Nz9 #cardiotwitter #TCT2023🏥💡

[AvertixMedical @AvertixMedical]

🚀 #TCT2023 Reminder: In minutes, Andrew Kaplan presents data on Avertix's #GUARDIAN system. Revolutionizing patient care at 3:36 PM PT! 🏥 #MedicalInnovations 🎉 #Cardiology

[AvertixMedical @AvertixMedical]

🚀 Avertix Medical's Guardian System shows 150% increase in heart attack survivor medication adjustments at #TCT2023. Kudos to @CMichaelGibson
and @AndrewJKaplanMD! Pioneering progress for personalized care. Read more:https://t.co/42FyQN6BzU #CardioTwitter #Cardiology #Guardian

[AvertixMedical @AvertixMedical]

Tune into @spac_insider for a thought-provoking conversation with Tim Moran of Avertix and Ross Haghighat of BIOS as they shed light on the SPAC experience and their vision for transforming cardiac care with the Guardian System. Listen now: https://t.co/PP9LvX1Q4F